Skip to main content

Table 3 Hematological and renal toxicity of treatment

From: Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

  

All (n = 61)

Valacyclovir (n = 15)

Valganciclovir (n = 16)

Foscarnet (n = 30)

P

Change in parameter (post-treatment – pre-treatment), median (range)

 

Creatinine (μM)

14 (−31 to 126)

2 (−31 to 57)

−2.5 (−70 to 73)

31.6 (−65 to 126)

0.009

 

ANC (x103/mm3)

−0.05 (−20.6 to 5.0)

0.19 (−4.2 to 3)

−1.5 (−7.5 to −1.1)

1.1 (−20.6 to 5.0)

0.012

 

Platelet (x103/mm3)

6 (−123 to 196)

6 (−72 to 82)

−7.5 (−123 to 196)

13 (−92 to 150)

0.335

  1. ANC, Absolute neutrophil count